{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:54:51Z","timestamp":1761490491845},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,3,12]],"date-time":"2018-03-12T00:00:00Z","timestamp":1520812800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1038\/s41440-018-0029-1","type":"journal-article","created":{"date-parts":[[2018,3,12]],"date-time":"2018-03-12T11:59:54Z","timestamp":1520855994000},"page":"342-353","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Risk of incident chronic kidney disease is better reduced by bedtime than upon-awakening ingestion of hypertension medications"],"prefix":"10.1038","volume":"41","author":[{"given":"Ram\u00f3n C.","family":"Hermida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana E.","family":"Ayala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Artemio","family":"Moj\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 R.","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,12]]},"reference":[{"key":"29_CR1","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1056\/NEJMoa011161","volume":"345","author":"BM Brenner","year":"2001","unstructured":"Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, Remuzzi G, Snapinn SM, Zhang Z, Shahinfar S. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 2001;345:861\u20139.","journal-title":"N Engl J Med"},{"key":"29_CR2","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1056\/NEJMoa011303","volume":"345","author":"EJ Lewis","year":"2001","unstructured":"Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, Ritz E, Atkins RC, Rohde R, Raz I. Renoprotective effects of the angiotensin-receptor antagonists irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med. 2001;345:851\u201360.","journal-title":"N Engl J Med"},{"key":"29_CR3","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.ajkd.2003.07.015","volume":"42","author":"JF Mann","year":"2003","unstructured":"Mann JF, Gerstein HC, Yi QL, Franke J, Lonn EM, Hoogwerf BJ, Rashkow A, Yusuf S, HOPE Investigators. Progression of renal insufficiency in type 2 diabetes with and without microalbuminuria: results of the Hearts Outcomes and Prevention Evaluation (HOPE) randomized study. Am J Kidney Dis. 2003;42:936\u201342.","journal-title":"Am J Kidney Dis"},{"key":"29_CR4","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1159\/000446862","volume":"43","author":"JB Cohen","year":"2016","unstructured":"Cohen JB, Stephems-Shields AJ, Denburg MR, Anderson AH, Townsend RR, Reese PP. Obesity, renin-angiotensin system blockade and risk of adverse renal outcomes: A population-based cohort study. Am J Neprol. 2016;43:431\u201340.","journal-title":"Am J Neprol"},{"key":"29_CR5","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3109\/07420528.2012.709448","volume":"30","author":"RC Hermida","year":"2013","unstructured":"Hermida RC, Ayala DE, Fern\u00e1ndez JR, Moj\u00f3n A, Smolensky MH, Fabbian F, Portaluppi F. Administration-time-differences in effects of hypertension medications on ambulatory blood pressure regulation. Chronobiol Int. 2013;30:280\u2013314.","journal-title":"Chronobiol Int"},{"key":"29_CR6","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/hr.2015.142","volume":"39","author":"RC Hermida","year":"2016","unstructured":"Hermida RC, Ayala DE, Smolensky MH, Fern\u00e1ndez JR, Moj\u00f3n A, Portaluppi F. Chronotherapy with conventional blood pressure medications improves management of hypertension and reduces cardiovascular and stroke risks. Hypertens Res. 2016;39:277\u201392.","journal-title":"Hypertens Res"},{"key":"29_CR7","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.smrv.2011.04.003","volume":"16","author":"F Portaluppi","year":"2012","unstructured":"Portaluppi F, Tiseo R, Smolensky MH, Hermida RC, Ayala DE, Fabbian F. Circadian rhythms and cardiovascular health. Sleep Med Rev. 2012;16:151\u201366.","journal-title":"Sleep Med Rev"},{"key":"29_CR8","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/hr.2016.166","volume":"40","author":"N Ohashi","year":"2017","unstructured":"Ohashi N, Isobe S, Ishigaki S, Yasuda H. Circadian rhythm of blood pressure and the renin-angiotensin system in the kidney. Hypertens Res. 2017;40:413\u201322.","journal-title":"Hypertens Res"},{"key":"29_CR9","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1161\/01.HYP.0000174616.36290.fa","volume":"46","author":"RC Hermida","year":"2005","unstructured":"Hermida RC, Calvo C, Ayala DE, L\u00f3pez JE. Decrease in urinary albumin excretion associated to the normalization of nocturnal blood pressure in hypertensive subjects. Hypertension. 2005;46:960\u20138.","journal-title":"Hypertension"},{"key":"29_CR10","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1097\/HJH.0b013e3283395267","volume":"28","author":"K Kario","year":"2010","unstructured":"Kario K, Hoshide S, Shimizu M, Yano Y, Eguchi K, Ishikawa J, Ishikawa S, Shimada K. Effects of dosing time of angiotensin II receptor blockade titrated by self-measured blood pressure recordings on cardiorenal protection in hypertensives: The Japan Morning Surge-Target Organ Protection (J-TOP) study. J Hypertens. 2010;28:1574\u201383.","journal-title":"J Hypertens"},{"key":"29_CR11","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3109\/10641963.2012.666604","volume":"34","author":"K Eguchi","year":"2012","unstructured":"Eguchi K, Shimizu M, Hoshide S, Shimada K, Kario K. A bedtime dose of ARB was better than a morning dose in improving baroreflex sensitivity and urinary albumin excretion\u2013the J-TOP study. Clin Exp Hypertens. 2012;34:488\u201392.","journal-title":"Clin Exp Hypertens"},{"key":"29_CR12","doi-asserted-by":"publisher","first-page":"416","DOI":"10.3109\/10641961003667948","volume":"32","author":"A Hoshino","year":"2010","unstructured":"Hoshino A, Nakamura T, Matsubara H. The bedtime administration ameliorates blood pressure variability and reduces urinary albumin excretion in amlodipine-olmesartan combination therapy. Clin Exp Hypertens. 2010;32:416\u201322.","journal-title":"Clin Exp Hypertens"},{"key":"29_CR13","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.3346\/jkms.2011.26.9.1185","volume":"26","author":"HR An","year":"2011","unstructured":"An HR, Park S, Yoo TH, Kang SW, Ryu JH, Lee YK, Yu M, Ryu DR, Kim SJ, Kang DH, Choi KB. Non-dipper status and left ventricular hypertrophy as predictors of incident chronic kidney disease. J Korean Med Sci. 2011;26:1185\u201390.","journal-title":"J Korean Med Sci"},{"key":"29_CR14","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1097\/HJH.0b013e328364dd0f","volume":"31","author":"A Kanno","year":"2013","unstructured":"Kanno A, Kikuya M, Asayama K, Satoh M, Inoue R, Hosaka M, Metoki H, Obara T, Hoshi H, Totsune K, Sato T, Taguma Y, Sato H, Imai Y, Ohkubo T. Night-time blood pressure is associated with the development of chronic kidney disease in a general population: the Ohasama Study. J Hypertens. 2013;31:2410\u20137.","journal-title":"J Hypertens"},{"key":"29_CR15","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1097\/HJH.0000000000000638","volume":"33","author":"CJ McMullan","year":"2015","unstructured":"McMullan CJ, Hickson DA, Taylor HA, Forman JP. Prospective analysis of the association of ambulatory blood pressure characteristics with incident chronic kidney disease. J Hypertens. 2015;33:1939\u201346.","journal-title":"J Hypertens"},{"key":"29_CR16","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.1681\/ASN.2016111186","volume":"28","author":"RC Hermida","year":"2017","unstructured":"Hermida RC, Ayala DE, Moj\u00f3n A, Fern\u00e1ndez JR. Sleep-time ambulatory BP is an independent prognostic marker of CKD. J Am Soc Nephrol. 2017;28:2802\u201311.","journal-title":"J Am Soc Nephrol"},{"key":"29_CR17","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1161\/HYPERTENSIONAHA.107.100727","volume":"51","author":"RH Fagard","year":"2008","unstructured":"Fagard RH, Celis H, Thijs L, Staessen JA, Clement DL, De Buyzere ML, De Bacquer DA. Daytime and nighttime blood pressure as predictors of death and cause-specific cardiovascular events in hypertension. Hypertension. 2008;51:55\u201361.","journal-title":"Hypertension"},{"key":"29_CR18","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/j.jacc.2011.04.043","volume":"58","author":"RC Hermida","year":"2011","unstructured":"Hermida RC, Ayala DE, Moj\u00f3n A, Fern\u00e1ndez JR. Decreasing sleep-time blood pressure determined by ambulatory monitoring reduces cardiovascular risk. J Am Coll Cardiol. 2011;58:1165\u201373.","journal-title":"J Am Coll Cardiol"},{"key":"29_CR19","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1097\/HJH.0000000000000355","volume":"32","author":"GC Roush","year":"2014","unstructured":"ABC-H Investigators, Roush GC, Fagard RH, Salles GF, Pierdomenico SD, Reboldi G, Verdecchia P, Eguchi K, Kario K, Hoshide S, Polonia J, de la Sierra A, Hermida RC, Dolan E, Zamalloa H. Prognostic impact from clinic, daytime, and nighttime systolic blood pressure in 9 cohorts on 13,844 patients with hypertension. J Hypertens. 2014;32:2332\u201340.","journal-title":"J Hypertens"},{"key":"29_CR20","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1038\/sj.ki.5000247","volume":"69","author":"R Agarwal","year":"2006","unstructured":"Agarwal R, Andersen MJ. Prognostic importance of ambulatory blood pressure recordings in patients with chronic kidney disease. Kidney Int. 2006;69:1175\u201380.","journal-title":"Kidney Int"},{"key":"29_CR21","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1681\/ASN.2011040361","volume":"22","author":"RC Hermida","year":"2011","unstructured":"Hermida RC, Ayala DE, Moj\u00f3n A, Fern\u00e1ndez JR. Bedtime dosing of antihypertensive medications reduces cardiovascular risk in CKD. J Am Soc Nephrol. 2011;22:2313\u201321.","journal-title":"J Am Soc Nephrol"},{"key":"29_CR22","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1001\/archinternmed.2011.230","volume":"171","author":"R Minutolo","year":"2011","unstructured":"Minutolo R, Agarwal R, Borrelli S, Chiodini P, Bellizzi V, Nappi F, Cianciaruso B, Zamboni P, Conte G, Gabbai FB, De Nicola L. Prognostic role of ambulatory blood pressure measurement in patients with nondialysis chronic kidney disease. Arch Intern Med. 2011;171:1090\u20138.","journal-title":"Arch Intern Med"},{"key":"29_CR23","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.3109\/07420528.2010.510230","volume":"27","author":"RC Hermida","year":"2010","unstructured":"Hermida RC, Ayala DE, Moj\u00f3n A, Fern\u00e1ndez JR. Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study. Chronobiol Int. 2010;27:1629\u201351.","journal-title":"Chronobiol Int"},{"key":"29_CR24","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s00125-015-3749-7","volume":"59","author":"RC Hermida","year":"2016","unstructured":"Hermida RC, Ayala DE, Moj\u00f3n A, Fern\u00e1ndez JR. Bedtime ingestion of hypertension medications reduces the risk of new-onset type 2 diabetes: a randomised controlled trial. Diabetologia. 2016;59:255\u201365.","journal-title":"Diabetologia"},{"key":"29_CR25","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3109\/07420528.2013.750490","volume":"30","author":"RC Hermida","year":"2013","unstructured":"Hermida RC, Smolensky MH, Ayala DE, Portaluppi F, Crespo JJ, Fabbian F, Haus E, Manfredini R, Moj\u00f3n A, Moy\u00e1 A, Pi\u00f1eiro L, R\u00edos MT, Otero A, Balan H, Fern\u00e1ndez JR2013 ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals. Chronobiol Int. 2013;30:355\u2013410.","journal-title":"Chronobiol Int"},{"key":"29_CR26","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1097\/01.hjh.0000431740.32696.cc","volume":"31","author":"G Mancia","year":"2013","unstructured":"Mancia G, Fagard R, Narkiewicz K, Red\u00f3n J, Zanchetti A, B\u00f6hm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P, Viigimaa M, Waeber B, Zannad F. 2013 ESH\/ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31:1281\u2013357.","journal-title":"J Hypertens"},{"key":"29_CR27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/kisup.2012.64","volume":"3","author":"Kidney Disease. Improving Global Outcomes (KDIGO) CKD Work Group.","year":"2013","unstructured":"Kidney Disease. Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Chapter 1: Definition and classification of CKD. Kidney Inter Suppl. 2013;3:19\u201362.","journal-title":"Kidney Inter Suppl"},{"key":"29_CR28","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/kisup.2012.65","volume":"3","author":"Kidney Disease. Improving Global Outcomes (KDIGO) CKD Work Group.","year":"2013","unstructured":"Kidney Disease. Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Chapter 2: Definition, identification, and prediction of CKD progression. Kidney Inter Suppl. 2013;3:63\u201372.","journal-title":"Kidney Inter Suppl"},{"key":"29_CR29","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang Y, Castro AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, for the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI). A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604\u201312.","journal-title":"Ann Intern Med"},{"key":"29_CR30","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.2337\/dc15-S004","volume":"38","author":"American Diabetes Association.","year":"2015","unstructured":"American Diabetes Association. Standards of Medical Care in Diabetes \u2013 2015. Diabetes Care. 2015;38:S5\u2013S87. suppl 1","journal-title":"Diabetes Care"},{"key":"29_CR31","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","volume":"112","author":"SM Grundy","year":"2005","unstructured":"Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Frauss RM, Savage PJ, Smith SC, Spertus JA, Costa F. Diagnosis and management of the metabolic syndrome. An American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735\u201352.","journal-title":"Circulation"},{"key":"29_CR32","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3109\/07420528.2012.701457","volume":"30","author":"RC Hermida","year":"2013","unstructured":"Hermida RC, Ayala DE, Fontao MJ, Moj\u00f3n A, Fern\u00e1ndez JR. Ambulatory blood pressure monitoring: Importance of sampling rate and duration \u2013 48 versus 24h \u2013 on the accurate assessment of cardiovascular risk. Chronobiol Int. 2013;30:55\u201367.","journal-title":"Chronobiol Int"},{"key":"29_CR33","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3109\/07420528.2012.701147","volume":"30","author":"C Crespo","year":"2013","unstructured":"Crespo C, Fern\u00e1ndez JR, Aboy M, Moj\u00f3n A. Clinical application of a novel automatic algorithm for actigraphy-based activity and rest period identification to accurately determine awake and asleep ambulatory blood pressure parameters and cardiovascular risk. Chronobiol Int. 2013;30:43\u201354.","journal-title":"Chronobiol Int"},{"key":"29_CR34","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1177\/1470320312470580","volume":"14","author":"Y Wang","year":"2013","unstructured":"Wang Y, Zhang MS, Liu Y. Nebivolol treatment improves resistant arterial function and reduces ventricular hyperthrophy and angiotensin II in spontaneously hypertension rats. J Renin Angiotensin Aldosterone Syst. 2013;14:146\u201355.","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"29_CR35","doi-asserted-by":"publisher","first-page":"192","DOI":"10.7326\/M14-1539","volume":"162","author":"MA Piper","year":"2015","unstructured":"Piper MA, Evans CV, Burda BU, Margolis KL, O\u2019Connor E, Whitlock EP. Diagnosis and predictive accuracy of blood pressure screening methods with consideration of rescreening intervals: A systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2015;162:192\u2013204.","journal-title":"Ann Intern Med"},{"key":"29_CR36","doi-asserted-by":"crossref","unstructured":"Zhao P, Xu P, Wan C, Wang Z. Evening versus morning dosing regimen drug therapy for hypertension. Cochrane Database Syst Rev. 2011;10:CD004184.","DOI":"10.1002\/14651858.CD004184.pub2"},{"key":"29_CR37","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1080\/07420528.2016.1181078","volume":"33","author":"RC Hermida","year":"2016","unstructured":"Hermida RC. Sleep-time ambulatory blood pressure as a prognostic marker of vascular and other risks and therapeutic target for prevention by hypertension chronotherapy: rationale and design of the Hygia Project. Chronobiol Int. 2016;33:906\u201336.","journal-title":"Chronobiol Int"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41440-018-0029-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41440-018-0029-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41440-018-0029-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:18:41Z","timestamp":1684617521000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-018-0029-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,12]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["29"],"URL":"https:\/\/doi.org\/10.1038\/s41440-018-0029-1","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,12]]},"assertion":[{"value":"5 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}